Harparkash Kaur
Overview
Explore the profile of Harparkash Kaur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
1282
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Redfern J, Kaur H, Adedoyin R, Ofori S, Anchala R, Vamadevan A, et al.
Glob Heart
. 2019 Aug;
14(3):327-333.
PMID: 31451241
Background: Widespread access to good quality antihypertensive medicines is a critical component for reducing premature cardiovascular disease (CVD) mortality. Poor-quality medicines pose serious health concerns; however, there remains a knowledge...
12.
Achan J, Reuling I, Yap X, Dabira E, Ahmad A, Cox M, et al.
Clin Infect Dis
. 2019 Aug;
70(12):2544-2552.
PMID: 31402382
Background: We assessed the impact of exposure to Plasmodium falciparum on parasite kinetics, clinical symptoms, and functional immunity after controlled human malaria infection (CHMI) in 2 cohorts with different levels...
13.
Passmore I, Letertre M, Preston M, Bianconi I, Harrison M, Nasher F, et al.
PLoS Pathog
. 2018 Sep;
14(9):e1007191.
PMID: 30208103
Clostridium difficile is a Gram-positive spore-forming anaerobe and a major cause of antibiotic-associated diarrhoea. Disruption of the commensal microbiota, such as through treatment with broad-spectrum antibiotics, is a critical precursor...
14.
Kaur H, Allan E, Mamadu I, Hall Z, Green M, Swamidos I, et al.
BMJ Glob Health
. 2017 Oct;
2(4):e000409.
PMID: 29082025
Introduction: Poor-quality artemisinin-containing antimalarials (ACAs), including falsified and substandard formulations, pose serious health concerns in malaria endemic countries. They can harm patients, contribute to the rise in drug resistance and...
15.
Schallig H, Tinto H, Sawa P, Kaur H, Duparc S, Ishengoma D, et al.
BMJ Glob Health
. 2017 Oct;
2(3):e000371.
PMID: 29082016
Background: Management of uncomplicated malaria relies on artemisinin-based combination therapies (ACTs). These highly effective regimens have contributed to reductions in malaria morbidity and mortality. However, artemisinin resistance in Asia and...
16.
Redfern J, Adedoyin R, Ofori S, Anchala R, Ajay V, de Andrade L, et al.
BMJ Glob Health
. 2017 Jun;
1(2):e000086.
PMID: 28588941
Background: Prevention and optimal management of hypertension in the general population is paramount to the achievement of the World Heart Federation (WHF) goal of reducing premature cardiovascular disease (CVD) mortality...
17.
Lalani M, Kitutu F, Clarke S, Kaur H
Malar J
. 2017 May;
16(1):197.
PMID: 28506234
Background: Assessing the quality of medicines in low-middle income countries (LMICs) relies primarily on human inspection and screening technologies, where available. Field studies and surveys have frequently utilized screening tests...
18.
Wilson B, Kaur H, Allan E, Lozama A, Bell D
Am J Trop Med Hyg
. 2017 Feb;
96(5):1117-1123.
PMID: 28219992
AbstractPoor-quality medicines are a major problem for health-care systems in resource-poor settings as identifying falsified medicines requires a complex laboratory infrastructure such as a Medicines Quality Control Laboratory. We report...
19.
Sutherland C, Lansdell P, Sanders M, Muwanguzi J, van Schalkwyk D, Kaur H, et al.
Antimicrob Agents Chemother
. 2017 Feb;
61(3).
PMID: 28137810
We present case histories of four patients treated with artemether-lumefantrine for falciparum malaria in UK hospitals in 2015 to 2016. Each subsequently presented with recurrent symptoms and parasitemia within 6...
20.
Hodel E, Kaur H, Terlouw D
Am J Trop Med Hyg
. 2016 Nov;
96(2):338-340.
PMID: 27895269
Dihydroartemisinin-piperaquine (DP) is recommended for the treatment of uncomplicated malaria, used in efforts to contain artemisinin resistance, and increasingly considered for mass drug administration. Because of the narrow therapeutic dose...